Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective Randomized Single Blind Phase III Trial Comparing Flexitouch Home Maintenance Therapy to Standard Home Maintenance Therapy for Lower Extremity Lymphedema Resulting From Treatment of Gynecologic Malignancy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00577317
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:08.180941+00:00
Published At
2021-06-23T00:00:00+00:00
Record Updated At
2021-06-23
Results Posted At
2021-06-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lymphedema", "Stage 0 Cervical Cancer", "Stage 0 Uterine Corpus Cancer", "Stage 0 Vulvar Cancer", "Stage I Uterine Corpus Cancer", "Stage I Vulvar Cancer", "Stage IA Cervical Cancer", "Stage IB Cervical Cancer", "Stage II Uterine Corpus Cancer", "Stage II Vulvar Cancer", "Stage IIA Cervical Cancer", "Stage IIB Cervical Cancer", "Stage III Cervical Cancer", "Stage III Uterine Corpus Cancer", "Stage III Vulvar Cancer", "Stage IV Uterine Corpus Cancer", "Stage IVA Cervical Cancer", "Stage IVB Cervical Cancer", "Stage IVB Vulvar Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-06-23"
protocolSection.identificationModule.nctId
"NCT00577317"
protocolSection.identificationModule.officialTitle
"A Prospective Randomized Single Blind Phase III Trial Comparing Flexitouch Home Maintenance Therapy to Standard Home Maintenance Therapy for Lower Extremity Lymphedema Resulting From Treatment of Gynecologic Malignancy"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-06-23"

Study condition terms

  • Lymphedema (protocolSection.conditionsModule.conditions)
  • Stage 0 Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage 0 Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage 0 Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage I Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage I Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage IA Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IB Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIA Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIB Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Vulvar Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Uterine Corpus Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Cervical Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Vulvar Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.